TextPower Inc closes oversubscribed Series A round with USD 525,000
TextPower raised capital commitments amounting to USD 525,000 in its Series A round.
Series A
National Science Board Favors Funding 'Extremely Large Telescope' With $1.6 Billion Over Other Telescopes
The National Science Board proposes $1.6 billion for a new "extremely large telescope" amid deliberations over two competing proposals.
Planet A Foods Raises $15.4 Million Funding to Expand Global Presence of Its Cocoa-Free Chocolate Brand
Planet A Foods has raised $15.4 million in Series A funding to expand the global presence of its cocoa-free chocolate brand...
Meet inploi — The Company Building the Hiring Infrastructure for the Global Economy
We spoke to Matt de la Hey, co-founder and CEO of inploi, the UK-based talent attraction scale-up...
Video Production Platform 90 Seconds Gets $8 Million Funding Led by Sequoia India; Aims for International Expansion
Online video production startup 90 Seconds will pursue its global expansion after securing $8 million in Series A led by Sequoia India. The startup will also broaden its network of creative freelancer..
Latest News
G1 Therapeutics raises USD 12.5 million in Series A funding round led by MedImmune Ventures
Pharmaceutical firm G1 Therapeutics scored USD 12.5 million from MedImmune Ventures and other investors in its Series A funding round.
Level receives USD 5 million in Series A funds from various investors
Mobile financial solutions provider Level initially closed its Series A funding round with USD 5 million.
Tempo DB raises USD3.2 million in Series A financing
In its latest Series A funding round, TempoDB would be expanding and developing its sensor and measurement data storage systems.
elevate DIGITAL receives Series A funding investments
Venture funding amounting to USD1.5 million in venture funding was received by elevate DIGITAL for its expansion and development purposes.
Pharmakea's Series A funding round receives investment from Bay City Capital
Pharmakea Therapeutics receive funding through Series A round from Bay City Capital and Celgene Corporation.
